Pharmacokinetic Profile of BIA 6-512 in Healthy Elderly Subjects Versus Healthy Young Subjects

Phase 1 Completed 25 enrolled Bial - Portela C S.A.

Non-randomizedParallel-groupOpen-labelTreatment

Summary

the purpose of the study was to the compare pharmacokinetic profile of BIA 6-512 in healthy elderly subjects versus healthy young subjects after single and repeated oral administration of 200 mg BIA 6-512.

Timeline

Start: 2006-01-24
Primary completion: 2006-03-02
Completion: 2006-03-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Resveratrol	Small molecule	200 mg	Oral

Pharmacokinetic Profile of BIA 6-512 in Healthy Elderly Subjects Versus Healthy Young Subjects

Summary

Timeline

Drugs

Indications